Skip to main content

Table 11 Association of collagen features with therapy response

From: The association between tumor-stromal collagen features and the clinical outcomes of patients with breast cancer: a systematic review

Association

Collagen Feature

p-value

Therapy

Invasive/In situ

Reference

Negative Association with Therapy Response

Ln F/B

p = 0.019

Tamoxifen

NA

[27]

Tortuosity (1–4), Angle (1–2), and Width (1–2)

p < 0.05

Chemotherapy (Paclitaxel) + HER2-Targeted Agents (Trastuzumab/Pertuzumab)

NA

[66]

Collagen Content

p = 0.005

Multi-therapy (Adriamycin/Cytoxan, Paclitaxel, Carboplatin, Bevacizumab)

Invasive

[47]

Collagen Volume

p < 0.001

NA

Invasive

[65]

Positive Association with Therapy Response

F/B (1)

p = 0.0246

NACT (a taxane, an anthracycline, cyclophosphamide, etoposide, 5-fluorouracil, methotrexate, and/or platinum therapy) + Mastectomy

NA

[64]

No Association with Therapy Response

F/B (2)

NS

Average fiber angle at the tumor boundary

  1. Definitions: F/B: (Higher value indicates larger fibril diameter, increased order in interfibrillar packing, and decreased fiber segmentation). Tortuosity 1: (90 th percentile tortuosity of fibers in tumor nest border). Tortuosity 2: (standard deviation of fiber tortuosity in tumor nest borders). Tortuosity 3: (mean tortuosity of fibers in tumor nest borders). Tortuosity 4: (median fiber tortuosity in densely inflamed stroma). Angle 1: (standard deviation of fiber relative-angles in bulk tumor borders). Angle 2: (proportion of fibers with high relative-angles in bulk tumor borders). Width 1: (kurtosis of fiber widths in tumor nest borders). Width 2: (skewness of fiber widths in tumor nest borders). F/B 1: (F/B in the tumor host interface of HER2+ patients, selecting pixels was based on an intensity threshold). F/B 2: (F/B in Triple-negative breast cancer patients)
  2. Abbreviations: NA Not Available, NS Not Significant, TACS Tumor-associated collagen signature, Ln F/B Natural logarithm of the Forward-to-Backward ratio, NACT Neoadjuvant Chemotherapy